Market Overview
Global Advanced Therapy Based on Gene market was valued at USD 12,500 million in 2024 and is projected to reach USD 48,250 million by 2031, at a CAGR of 21.8% during the forecast period.
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. It encompasses gene therapy, cell therapy, and gene editing techniques aimed at modifying or replacing faulty genes to address diseases at the genetic level.
USD 12,500 million in 2024
USD 48,250 million by 2031
of 21.8%
Monoolein Segment Dominates the Market Due to its Stability and Versatility in Membrane Protein Studies
1.The market is segmented based on type into: Monoolein Monopalmitolein
Others
Structure Determination for Drug Design
The
https://www.24lifesciences.com
Our Key Players
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
